The Enterprise Value as of November 2024 (TTM) for Clene Inc. (CLNN) is 56.08M

According to Clene Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 56.08M. This represents a change of -94.46% compared to the average of 1.01B of the last 4 quarters.

Clene Inc. (CLNN) Historical Enterprise Value (quarterly & annually)

How has CLNN Enterprise Value performed in the past?

The mean historical Enterprise Value of Clene Inc. over the last ten years is 3.09B. The current 56.08M Enterprise Value has changed 81.39% with respect to the historical average. Over the past ten years (40 quarters), CLNN's Enterprise Value was at its highest in in the March 2021 quarter at 15.46B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Clene Inc. (CLNN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Clene Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clene Inc. (CLNN) Average Enterprise Value

How has CLNN Enterprise Value performed in the past?

The current Enterprise Value of Clene Inc. (CLNN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Clene Inc. (CLNN) Enterprise Value vs. Peers

How is CLNN’s Enterprise Value compared to its peers?

Clene Inc.’s Enterprise Value is less than MediciNova, Inc. (0), greater than Eliem Therapeutics, Inc. (38.55M), less than Molecular Partners AG (119.64M), less than Champions Oncology, Inc. (57.68M), less than Cyteir Therapeutics, Inc. (61.85M), greater than Century Therapeutics, Inc. (-20511738.00), less than Kezar Life Sciences, Inc. (121.66M), greater than Mineralys Therapeutics, Inc. (41.06M), less than Nkarta, Inc. (603.45M), less than NGM Biopharmaceuticals, Inc. (193.08M), less than Ikena Oncology, Inc. (69.72M), greater than Foghorn Therapeutics Inc. (47.83M), less than Werewolf Therapeutics, Inc. (357.88M), greater than Immunome, Inc. (139.97K), less than Sensei Biotherapeutics, Inc. (606.74M), greater than NextCure, Inc. (6.21M), greater than Nuvation Bio Inc. (21.96M), less than Graphite Bio, Inc. (1.02B), greater than Merrimack Pharmaceuticals, Inc. (-15007658.00), greater than null (-10189682.00),

Build a custom stock screener for Clene Inc. (CLNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clene Inc. (CLNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.